R. Davies

发表

The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling

Xinnan Wang, J. Luzio, H. T. Tsang, 2009, Human molecular genetics.

BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production

I. Adcock, M. Griffiths, N. Morrell, 2012, PloS one.

Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.

N. Morrell, R. Davies, 2008, Chest.

Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells

M. Griffiths, N. Morrell, R. Davies, 2020, Journal of Cell Science.

TGF-β/BMP Signaling in Pulmonary Vascular Disease

N. Morrell, R. Davies, 2008 .

B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases.

D. D'cruz, M. Khamashta, S. Sangle, 2013, Journal of autoimmunity.

Pulmonary vascular disease: pulmonary thromboembolism and pulmonary hypertension

R. Davies, L. Howard, 2012, Medicine.

C Up to 5% of patients with acute pulmonary embolism will go on to develop chronic thrombo-embolic pulmonary hypertension C Only 75% of patients with confirmed pulmonary embolism will

R. Davies, L. Howard, 2012 .

MRI Feature Tracking Strain in Pulmonary Hypertension: Utility of Combined Left Atrial Volumetric and Deformation Assessment in Distinguishing Post- From Pre-capillary Physiology

R. Davies, D. Gopalan, L. Howard, 2021, Frontiers in Cardiovascular Medicine.

Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.

K. Dimopoulos, J. Lordan, S. Kemp, 2021, British journal of anaesthesia.

Thymosin β4 mediates vascular protection via regulation of Low Density Lipoprotein Related Protein 1 (LRP1)

J. Patel, K. Channon, R. Davies, 2019, bioRxiv.

Left Main Bronchus Compression Due to Main Pulmonary Artery Dilatation in Pulmonary Hypertension: Two Case Reports

D. O’Regan, B. Ariff, R. Davies, 2015, Pulmonary circulation.

Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline.

Cerys Docx, C. Leblanc, N. Morrell, 2009, The American journal of pathology.

Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.

K. Murphy, R. Davies, L. Howard, 2016, Journal of applied physiology.

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension

P. Robbins, D. Ashby, N. Morrell, 2013, Pulmonary circulation.

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study

K. Dimopoulos, A. Peacock, J. Yorke, 2020, European Respiratory Journal.

Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.

N. Morrell, R. Davies, T. Tajsic, 2013, American journal of respiratory cell and molecular biology.

Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure

C. Shovlin, R. Davies, J. Gibbs, 2008, European Respiratory Journal.

Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells*

R. Trembath, N. Morrell, R. Davies, 2009, The Journal of Biological Chemistry.

BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.

N. Morrell, D. Budd, A. Holmes, 2012, American journal of physiology. Lung cellular and molecular physiology.

Mutations in Bone Morphogenetic Protein Type II Receptor Cause Dysregulation of Id Gene Expression in Pulmonary Artery Smooth Muscle Cells: Implications for Familial Pulmonary Arterial Hypertension

R. Trembath, N. Morrell, R. Davies, 2008, Circulation research.

COVID-19 and its impact on the cardiovascular system

C. Plymen, P. Nihoyannopoulos, J. Kooner, 2021, Open Heart.

Response to Pulmonary Arterial Hypertension Drug Therapies in Patients with Pulmonary Arterial Hypertension and Cardiovascular Risk Factors

J. Grapsa, P. Nihoyannopoulos, I. Tzoulaki, 2014, Pulmonary circulation.

Hepatic Artery Stenosis in Antiphospholipid Syndrome

D. D'cruz, S. Sangle, R. Davies, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Utility of cardiac magnetic resonance feature tracking strain assessment in chronic thromboembolic pulmonary hypertension for prediction of REVEAL 2.0 high risk status

R. Davies, D. Gopalan, L. Howard, 2022, Pulmonary circulation.

Thymosin β4 protects against aortic aneurysm via endocytic regulation of growth factor signaling

K. Channon, M. Sattler, R. Fischer, 2021, The Journal of clinical investigation.

muscle cells: role of proinflammatory cytokines in pulmonary artery smooth β growth inhibition by TGF- BMP type II receptor deficiency confers resistance to

N. Morrell, D. Budd, A. Holmes, 2016 .